Clark Capital Management Group Inc. raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 4.3% in the first quarter, HoldingsChannel reports. The institutional investor owned 233,740 shares of the healthcare conglomerate’s stock after purchasing an additional 9,533 shares during the period. UnitedHealth Group accounts for about 0.9% of Clark Capital Management Group Inc.’s holdings, making the stock its 20th biggest position. Clark Capital Management Group Inc.’s holdings in UnitedHealth Group were worth $122,421,000 at the end of the most recent reporting period.
A number of other institutional investors also recently modified their holdings of the stock. Banque Transatlantique SA lifted its stake in shares of UnitedHealth Group by 16.6% in the 1st quarter. Banque Transatlantique SA now owns 2,905 shares of the healthcare conglomerate’s stock valued at $1,406,000 after purchasing an additional 414 shares during the last quarter. AQR Capital Management LLC lifted its stake in shares of UnitedHealth Group by 251.5% in the 1st quarter. AQR Capital Management LLC now owns 784,689 shares of the healthcare conglomerate’s stock valued at $410,981,000 after purchasing an additional 561,451 shares during the last quarter. Alyeska Investment Group L.P. lifted its stake in shares of UnitedHealth Group by 21.1% in the 1st quarter. Alyeska Investment Group L.P. now owns 70,000 shares of the healthcare conglomerate’s stock valued at $36,662,000 after purchasing an additional 12,198 shares during the last quarter. Appaloosa LP lifted its stake in shares of UnitedHealth Group by 0.3% in the 1st quarter. Appaloosa LP now owns 175,000 shares of the healthcare conglomerate’s stock valued at $91,656,000 after purchasing an additional 500 shares during the last quarter. Finally, Aprio Wealth Management LLC lifted its stake in shares of UnitedHealth Group by 10.0% in the 1st quarter. Aprio Wealth Management LLC now owns 1,471 shares of the healthcare conglomerate’s stock valued at $770,000 after purchasing an additional 134 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.
UnitedHealth Group Stock Performance
NYSE:UNH opened at $307.27 on Thursday. The firm’s 50-day moving average is $288.51 and its 200-day moving average is $377.17. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The company has a market cap of $278.29 billion, a price-to-earnings ratio of 13.31, a PEG ratio of 2.00 and a beta of 0.45.
UnitedHealth Group Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be issued a $2.21 dividend. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.9%. UnitedHealth Group’s dividend payout ratio is presently 38.30%.
Analysts Set New Price Targets
Several equities research analysts recently issued reports on the stock. Bank of America lifted their price objective on shares of UnitedHealth Group from $290.00 to $325.00 and gave the company a “neutral” rating in a research note on Monday, August 18th. Baird R W lowered shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 31st. JPMorgan Chase & Co. cut their target price on shares of UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating for the company in a research report on Wednesday, August 6th. Cantor Fitzgerald reissued an “overweight” rating and set a $440.00 target price on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Finally, Hsbc Global Res lowered shares of UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a research report on Wednesday, May 21st. Fifteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus price target of $353.00.
Insider Activity
In other news, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the transaction, the chief executive officer directly owned 10,398 shares of the company’s stock, valued at approximately $3,171,390. This represents a 5.36% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 0.28% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- The Role Economic Reports Play in a Successful Investment Strategy
- Return of the ETFs: 3 Names That Could Keep Outperforming
- Insider Buying Explained: What Investors Need to Know
- Back-to-School Shopping Hits $40B: 3 Retail Stocks to Watch Now
- 3 Fintech Stocks With Good 2021 Prospects
- Alphabet Stock Surges After Dodging Harsh Antitrust Remedies
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.